다우존스 지수

브라질 증권 거래소, NASDAQ, NYSE, AMEX, LSE 등 주요 거래소에서의 다양한 실시간 주식 시세를 모니터링합니다.

등록

홈
인베스팅
주식
미국
NASDAQ
Vanda Pharmaceuticals Inc (VNDA)
Vanda Pharmaceuticals Inc (VNDA) 뉴스

VNDA

Vanda Pharmaceuticals (VNDA)

Vanda Pharmaceuticals Inc

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:VNDA

<< 이전 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2022/12/14	05:15	PR Newswire (US)	Vanda Pharmaceuticals Responds to Ruling in HETLIOZ® ANDA Litigation	NASDAQ:VNDA	Vanda Pharmaceuticals Inc
2022/12/14	03:24	Dow Jones News	Vanda Pharmaceuticals Shares Tumble After Loss in Hetlioz Patent Suit	NASDAQ:VNDA	Vanda Pharmaceuticals Inc
2022/12/08	07:59	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:VNDA	Vanda Pharmaceuticals Inc
2022/12/08	07:58	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:VNDA	Vanda Pharmaceuticals Inc
2022/12/02	21:00	PR Newswire (US)	Vanda Pharmaceuticals Reports Results in a Phase II Clinical Study of VQW-765 in the Treatment of Acute Performance Anxiety	NASDAQ:VNDA	Vanda Pharmaceuticals Inc
2022/11/09	10:30	PR Newswire (US)	Vanda Pharmaceuticals Announces Participation at November 2022 Investor Conferences	NASDAQ:VNDA	Vanda Pharmaceuticals Inc
2022/11/03	20:04	Edgar (US Regulatory)	Quarterly Report (10-q)	NASDAQ:VNDA	Vanda Pharmaceuticals Inc
2022/11/03	05:01	PR Newswire (US)	Vanda Pharmaceuticals Reports Third Quarter 2022 Financial Results	NASDAQ:VNDA	Vanda Pharmaceuticals Inc
2022/10/27	07:00	PR Newswire (US)	Vanda Pharmaceuticals to Announce Third Quarter 2022 Financial Results on November 2, 2022	NASDAQ:VNDA	Vanda Pharmaceuticals Inc
2022/10/22	03:00	PR Newswire (US)	Vanda Pharmaceuticals Announces Orphan Drug Designation Granted for VPO-227, a Novel Candidate for the Treatment of Cholera	NASDAQ:VNDA	Vanda Pharmaceuticals Inc
2022/09/30	05:30	PR Newswire (US)	Vanda Pharmaceuticals and OliPass Announce Strategic Partnership to Develop Antisense Oligonucleotide Therapeutics	NASDAQ:VNDA	Vanda Pharmaceuticals Inc
2022/09/09	07:00	PR Newswire (US)	Vanda Pharmaceuticals Announces Participation in the H.C. Wainwright Global Investment Conference	NASDAQ:VNDA	Vanda Pharmaceuticals Inc
2022/09/08	08:34	Dow Jones News	Vanda Pharmaceuticals Gets Notice of Opportunity for FDA Meeting	NASDAQ:VNDA	Vanda Pharmaceuticals Inc
2022/09/08	07:38	PR Newswire (US)	VANDA PHARMACEUTICALS ANNOUNCES NOTICE OF OPPORTUNITY FOR AN FDA HEARING ON THE sNDA FOR HETLIOZ® IN JET LAG DISORDER	NASDAQ:VNDA	Vanda Pharmaceuticals Inc
2022/08/18	05:07	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:VNDA	Vanda Pharmaceuticals Inc
2022/08/04	05:01	PR Newswire (US)	Vanda Pharmaceuticals Reports Second Quarter 2022 Financial Results	NASDAQ:VNDA	Vanda Pharmaceuticals Inc
2022/08/02	05:46	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:VNDA	Vanda Pharmaceuticals Inc
2022/07/28	06:30	PR Newswire (US)	Vanda Pharmaceuticals to Announce Second Quarter 2022 Financial Results on August 3, 2022	NASDAQ:VNDA	Vanda Pharmaceuticals Inc
2022/06/22	05:56	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:VNDA	Vanda Pharmaceuticals Inc
2022/06/22	05:55	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:VNDA	Vanda Pharmaceuticals Inc
2022/06/22	05:55	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:VNDA	Vanda Pharmaceuticals Inc
2022/06/22	05:54	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:VNDA	Vanda Pharmaceuticals Inc
2022/06/18	05:16	Edgar (US Regulatory)	Securities Registration: Employee Benefit Plan (s-8)	NASDAQ:VNDA	Vanda Pharmaceuticals Inc
2022/06/17	05:17	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:VNDA	Vanda Pharmaceuticals Inc
2022/06/04	05:31	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:VNDA	Vanda Pharmaceuticals Inc
2022/06/03	05:30	PR Newswire (US)	Vanda Pharmaceuticals Announces Participation in the Jefferies 2022 Global Healthcare Conference	NASDAQ:VNDA	Vanda Pharmaceuticals Inc
2022/06/01	07:00	PR Newswire (US)	Vanda Pharmaceuticals Announces Presentations at SLEEP 2022	NASDAQ:VNDA	Vanda Pharmaceuticals Inc
2022/05/20	08:00	PR Newswire (US)	Vanda Pharmaceuticals Announces Presentations at DDW 2022	NASDAQ:VNDA	Vanda Pharmaceuticals Inc
2022/05/06	05:10	PR Newswire (US)	Vanda Pharmaceuticals Reports First Quarter 2022 Financial Results	NASDAQ:VNDA	Vanda Pharmaceuticals Inc
2022/05/05	05:30	PR Newswire (US)	Vanda Pharmaceuticals Announces Participation in the BofA Securities 2022 Healthcare Conference	NASDAQ:VNDA	Vanda Pharmaceuticals Inc

검색 관련기사 보기:NASDAQ:VNDA

<< 이전 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 다음 >>

Global Star Acquisition

Delayed Upgrade Clock

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관